rMark Bio has designed a blueprint for transforming healthcare data into real-time business intelligence. Our proprietary deep learning platform analyzes global healthcare data in-conjunction with internal clinical research data to optimize partnership and engagement strategies across the life-cycle of a product for healthcare industries including; pharmaceutical, academic institutions, medical device companies, and investment firms. By leveraging rMark Bio’s platform, organizations can significantly reduce time and cost of data analysis while increasing opportunities to align real-time business strategies between their R&D, Product, Commercialization and external teams
Looking for a particular rMark Bio, Inc. employee's phone or email?
The rMark Bio, Inc. annual revenue was $7 million in 2026.
rMark Bio, Inc. is based in Chicago, Illinois.
The NAICS codes for rMark Bio, Inc. are [541714, 54, 541, 5417, 54171].
The SIC codes for rMark Bio, Inc. are [873, 87].